Project title/計畫英文名
An Open Label, Phase II Trial of Afatinib with Paclitaxel for the Neoadjuvant Treatment of Triple-Negative Breast Cancer and Research of Biomarkers of Activity and Efficacy of Afatinib( III )
Project Number/計畫編號
MOST105-2325-B002-013
Translated Name/計畫中文名
評估Afatinib合併太平洋紫杉醇用於三陰性乳癌之術前治療第II期臨床試驗的療效並尋求可預測Afatinib有效性之生物標記( III )
Project Principal Investigator/計畫主持人
Funding Organization
Co-Investigator(s)/共同執行人
侯明鋒 俞志誠 曾令民 劉良智 張宏泰 葉大成 張源清
Start date/計畫起
01-08-2016
Expected Completion/計畫迄
12-05-2017